CARE Ratings Ltd is Rated Hold by MarketsMOJO

Current Rating and Its Significance

MarketsMOJO’s 'Hold' rating for CARE Ratings Ltd indicates a balanced outlook on the stock, suggesting that investors should maintain their existing positions rather than aggressively buying or selling. This rating reflects a comprehensive assessment of the company’s quality, valuation, financial trend, and technical indicators as they stand today. The rating was revised on 03 July 2026, when the Mojo Score decreased from 71 to 64, signalling a shift from a 'Buy' to a 'Hold' stance. This change underscores a more cautious approach given the current market and company-specific factors.

How CARE Ratings Ltd Looks Today: Quality Assessment

As of 17 July 2026, CARE Ratings Ltd maintains a good quality grade. The company is net-debt free, which is a strong indicator of financial stability and prudent capital management. Over the past five years, the company has demonstrated steady growth with net sales increasing at an annualised rate of 13.75% and operating profit growing at 15.76%. Furthermore, CARE Ratings has reported positive results for 11 consecutive quarters, highlighting consistent operational performance.

The company’s return on capital employed (ROCE) for the half-year period stands at an impressive 24.81%, reflecting efficient use of capital to generate profits. Profit before tax excluding other income (PBT less OI) has grown at a robust 28.77%, while quarterly profit after tax (PAT) has increased by 24.0%. These metrics collectively affirm the company’s strong operational quality and earnings growth trajectory.

Valuation: A Premium Price Tag

Despite solid fundamentals, CARE Ratings Ltd is currently considered very expensive based on valuation metrics. The stock trades at a price-to-book value of 5.4, which is significantly higher than the average historical valuations of its peers in the capital markets sector. This premium valuation reflects investor confidence in the company’s growth prospects but also suggests limited upside potential at current price levels.

As of 17 July 2026, the company’s return on equity (ROE) is 18.4%, which is healthy but does not fully justify the elevated valuation. The price-to-earnings-to-growth (PEG) ratio stands at 1.2, indicating that while earnings growth is strong, the stock price has already factored in much of this growth. Over the past year, the stock has delivered a negative return of -7.16%, contrasting with a 24.7% increase in profits, which further highlights the valuation premium investors are paying.

Financial Trend: Positive Momentum with Caution

The financial trend for CARE Ratings Ltd remains positive. The company’s consistent quarterly profit growth and strong ROCE demonstrate a healthy earnings momentum. However, the long-term growth rate, while steady, is moderate with net sales and operating profit growing in the mid-teens annually. This steady but unspectacular growth rate suggests that while the company is financially sound, it may not deliver explosive returns in the near term.

Institutional investors hold a significant 54.99% stake in the company, reflecting confidence from sophisticated market participants who typically have deeper insights into company fundamentals. This high institutional holding can provide stability to the stock price but also means that retail investors should carefully consider valuation before initiating new positions.

Technical Outlook: Mildly Bullish Signals

From a technical perspective, CARE Ratings Ltd is rated as mildly bullish. The stock has shown modest gains over recent periods, with a 1-month return of +0.89%, 3-month return of +2.66%, and a 6-month return of +3.29%. Year-to-date, the stock has appreciated by 3.95%, indicating some positive price momentum despite the recent slight dip of -0.47% on the day of analysis.

These technical indicators suggest that while the stock is not in a strong uptrend, it is maintaining a stable price base with potential for moderate appreciation. Investors relying on technical analysis may view this as a signal to hold rather than initiate new positions at this stage.

Implications for Investors

For investors, the 'Hold' rating on CARE Ratings Ltd suggests a cautious stance. The company’s strong quality metrics and positive financial trends provide a solid foundation, but the very expensive valuation limits the potential for significant capital gains in the near term. Investors already holding the stock may choose to maintain their positions to benefit from steady earnings growth and dividend prospects, while new investors might consider waiting for a more attractive entry point.

Given the high institutional ownership and consistent quarterly performance, the stock is unlikely to experience extreme volatility, making it suitable for investors with a moderate risk appetite seeking exposure to the capital markets sector. However, the premium valuation and modest price momentum imply that upside may be limited unless the company can accelerate growth or improve profitability beyond current levels.

Summary

In summary, CARE Ratings Ltd’s current 'Hold' rating by MarketsMOJO, updated on 03 July 2026, reflects a balanced view of the company’s prospects as of 17 July 2026. The stock exhibits strong quality and positive financial trends but is priced at a premium valuation with only mild technical momentum. Investors should weigh these factors carefully when considering their portfolio allocation to CARE Ratings Ltd.

Company Profile and Market Context

CARE Ratings Ltd operates within the capital markets sector as a small-cap company. Its net-debt-free status and consistent profitability over multiple quarters underscore its operational resilience. The company’s market capitalisation and sector positioning make it a noteworthy player for investors seeking exposure to credit rating agencies and related financial services.

While the broader market environment remains dynamic, CARE Ratings Ltd’s fundamentals provide a degree of stability. The stock’s recent performance, including a 1-year return of -7.16%, contrasts with its profit growth of 24.7%, highlighting a disconnect between market pricing and earnings growth that investors should monitor closely.

Final Considerations

Ultimately, the 'Hold' rating serves as a prudent recommendation for investors to maintain their current exposure without committing additional capital at this time. Monitoring future earnings releases, valuation shifts, and technical developments will be essential to reassess the stock’s attractiveness in the coming months.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →